Pharmaleads today announces its participation at the upcoming 10th Annual Biotech Showcase Conference to be held in San Francisco on January 8 - 10, 2018.
Paris, France, 3rd January 2018 - Pharmaleads, an emerging pharmaceutical company developing innovative non-opiate and non-addictive products for the management of acute and chronic severe pain, today announces its participation at the upcoming 10th Annual Biotech Showcase™ Conference to be held in San Francisco (CA, United States) on January 8 – 10, 2018. Thierry Bourbié, CEO of Pharmaleads, will provide a corporate update and pipeline overview at the conference.
Presentation Details:
- Date: Monday 8th January 2018
- Time: 2:00 pm PT
- Duration: 15 minutes
- Location: Room D - Ballroom at the Hilton San Francisco Union Square
Thierry Bourbié, CEO of Pharmaleads, said, “We are delighted to be presenting at this highly respected and well-attended investor conference. We believe our presentation at Biotech Showcase will provide investors with an exciting overview of Pharmaleads cutting-edge pipeline of Dual ENKephalinase Inhibitors for the management of acute and chronic severe pain. Our compounds have the potential to completely change the game in the opioid crisis by providing safe and non-addictive pain relief to patients suffering from severe pain of all types.”
Biotech Showcase™ is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.
